Annika Bansal – Lifestyle
Author:
Ernexa Therapeutics Inc.
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
April 30, 2026
Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
March 31, 2026